Nucleated red blood cell analysis system and method
AssigneeAbbott Laboratories
InventorsJiong Wu, Marilou Coleman, Emily H. Lin, Michael R. Buhl, Giacomo Vacca
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbbott Laboratories
InventorsJiong Wu, Marilou Coleman, Emily H. Lin, Michael R. Buhl, Giacomo Vacca
Estimating the term…
Systems and methods for analyzing blood samples, and more specifically for performing a nucleated red blood cell (nRBC) analysis. The systems and methods screen a blood sample by means of fluorescence staining and a fluorescence triggering strategy, to identify nuclei-containing particles within the blood sample. As such, interference from unlysed red blood cells (RBCs) and fragments of lysed RBCs is substantially eliminated. The systems and methods also enable development of relatively milder reagent(s), suitable for assays of samples containing fragile white blood cells (WBCs). In one embodiment, the systems and methods include: (a) staining a blood sample with an exclusive cell membrane permeable fluorescent dye; (b) using a fluorescence trigger to screen the blood sample for nuclei-containing particles; and (c) using measurements of light scatter and fluorescence emission to distinguish nRBCs from WBCs.
A hematology analyzer for conducting a nucleated red blood cell (nRBC) analysis on a blood sample that contains a plurality of nRBCs, the analyzer comprising:
Dependencies are inferred from the claim text.